EGIP is specialized in medicine that needs a prescription from a licensed physician. In the past decade EGIP has registered more than almost a hundred products with the Food and Drug Administration (FDA), many of them are now well accepted in the Philippine market. The products are being distributed through a nationwide network that includes reputable marketing and distribution companies with principal offices in Manila and Davao and one major distributing company (Metro Drug). Some of the company’s major brands (Provasc, Afunginal, Kenzar, Normanal, Regecef, and Clovix) are available in the country’s leading drug chain (Mercury). In the coming years EGIP will continue development of quality generic drugs in selected areas of medicine where there is greater need in order to continue and further improve its service to the Philippine people.
EGIP is a private enterprise on the initiative of Dr. Hubertus van Dierendonck, a Dutch national, who is a permanent resident of the Philippines since 1982. Dr. Bert worked many years as physician in some remote parts of the country, where he learned much about health and medicine in the Philippines. His company Euro Generics is a continuation of his endeavors to provide affordable medicine to the Philippine people. Part of his vision for a strong and successful company was:
1. Sign contracts with state of the art manufacturing companies to ensure 100% quality of
products,
2. Establish sound logistics and finance to ensure speedy and reliable delivery of goods
3. Always give priority to the company’s staff. The company’s present success can be
contributed to a professional staff, which is highly motivated and dedicated to the
company’s vision.
Contact Information:
Address: Suites D & E, 11F Burgundy Corporate Tower 252 Sen Gil Puyat Ave., Brgy. San
Lorenzo, Makati City, Philippines
Phone: (+63) (02) 856-4325
Fax: (+63) (02) 856-5812
Email: eurogenerics@yahoo.com
The biggest pharma stories from Southeast Asia, including GSK’s new HPF manufacturing investment, license suspensions for Samco Farma and Ciubros Farma after Indonesia’s acute kidney injury crisis, Kalbe’s Aventis share…
The latest from the pharma industry in Southeast Asia, including underwhelming results from Kalbe Pharma, Indonesia’s largest pharma company; Novavax’s vaccine manufacturing plans in the Philippines; the promising future of…
Ramon Aristoza, acting President and CEO of PhilHealth, discusses the current challenges the organization is facing in terms of realizing the goal of universal healthcare for the Filipino population, their…
The election of maverick former mayor of Davao, Rodrigo Duterte to the Filipino presidency in May 2016 represented a dramatic departure from politics as usual and raised interesting questions about…
Ravinder S. Singha, the Managing Director of Firmlink Pharma, discusses the unique business model they offer to their clients, their key success factors in entering new and sometimes challenging markets,…
Jingle Garcia Diola, Executive Director at Firmlink Pharma, details the company’s value-added services and how they are positioning themselves as the business development partner of choice for large local and…
Javish Abichandani, Chief Executive Officer of AGlobal Care Inc. in the Philippines, outlines the company’s extensive product portfolio as well as their ambitions to bring more high-quality, affordable medications into…
Jose Augusto Pascual, President and CEO of PascualLab, sheds light on the company’s current footprint in the Philippines, as well as their ambitions to even further expand their manufacturing capabilities.…
Cheryl Maley, General Manager of Novartis Philippines, discusses the company’s operations in the country, their growing portfolio of products as well as their impressive focus on research and development in…
Meneleo Hernandez, Jr., President of Multicare, describes Lupin Pharma’s Multicare operations in the Philippines and how their niche business unit strategy and strategic partnerships create a sustainable business model that…
Ivan Alexi Arota, country manager of GE Healthcare Philippines, discusses the company’s extensive efforts to increase access to their innovative, affordable products throughout the country. He also expands on the…
Bakhuti Shengelia, Director Healthcare Systems of Novartis International AG, expands on Novartis’ initiatives to increase access to healthcare in emerging markets as well as the importance of transitioning towards value-based…
See our Cookie Privacy Policy Here
